Thought Leadership
Search results
Blog | December 24, 2013
SDNY comments on EMVR's application in pharma context
Fish & Richardson
Read more
Blog | December 23, 2013
DUtah Uses Infringer's Profits to Compute Royalty; Comments on Obligation to Award Reasonable Royalty
Fish & Richardson
Read more
Article | December 20, 2013
Read more
Timing of PTO Disclosures - A Trap for the Unwary
Pharmaceutical Compliance Monitor
Blog | December 18, 2013
Read more
SDNY orders ongoing royalty as percentage of wholesale price
Fish & Richardson
Blog | November 25, 2013
NDCA precludes lost profits where damage was to plaintiff's related entity, not plaintiff itself
Fish & Richardson
Read more
Blog | November 22, 2013
Update on pleading standards in Hatch-Waxman cases
Fish & Richardson
Read more
Article | November 22, 2013
Read more
Hatch-Waxman Developments: Artificial Infringement by Artificial Drugs
Pharmaceutical Compliance Monitor
Blog | November 20, 2013
Avalanche Preparedness: An Official Way to See What's Coming
Fish & Richardson
Read more
Blog | November 19, 2013
WDPA relies on Lucent to allow royalty base of entire product revenue where rate is sufficiently small
Fish & Richardson
Read more
Blog | November 16, 2013
Garmin International, Inc. v. Cuozzo Speed Technologies, LLC, IPR2012-00001, Paper 59 (PTAB Nov. 13, 2013).
Fish & Richardson
Read more
Blog | November 15, 2013
Federal District Court of New York Holds Google Books Project Is Fair Use
Fish & Richardson
Read more